Chung Jane
- SEC CIK
- 0001872398
In the past year, 1 open-market purchase filing worth $10.0K and no sales.
Current role at each company
- STRO Sutro Biopharma, Inc.Chief Executive Officeras of Mar 6, 2026
- VIRX Viracta Therapeutics, Inc.Directoras of Jun 24, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $10.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$10.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chung Jane as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STRO Sutro Biopharma, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 (view filing) | Oct 15 | 1 day | Chung JaneChief Executive Officer | PPurchase | +12.5K | $0.80 | +$10.0K | +11.3%122.8K after |